Strumento inattivo

Altre lingue Corbus Pharmaceuticals Holdings Inc OTC Bulletin Board

Azioni

US21833P1030

Prezzo di chiusura OTC Bulletin Board Altri mercati azionari
- ^USD	-

12/06	Transcript : Corbus Pharmaceuticals Holdings, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 02:40 PM
11/06	CORBUS PHARMACEUTICALS HOLDINGS, INC. : giudizio positivo da RBC Capital Markets	ZM

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Corbus Pharmaceuticals Reaches 2-Year High After Drug Results	03/06
SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024	01/06
Corbus Pharmaceuticals Presents Positive Clinical Update on SYS6002 (CRB-701) at ASCO Conference	01/06
Corbus Pharmaceuticals to Present at the 45th Annual Goldman Sachs Global Healthcare Conference	30/05
Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting	23/05
Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference	09/05
Corbus Pharmaceuticals: Q1 Earnings Snapshot	07/05
Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update	07/05
Corbus Pharmaceuticals Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum	01/05
Certain Restricted Stock Units of Corbus Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agreement Ending on 1-MAY-2024.	01/05
Certain Warrants of Corbus Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agreement Ending on 1-MAY-2024.	01/05
Certain Options of Corbus Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agreement Ending on 1-MAY-2024.	01/05
Certain Common Stock of Corbus Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agreement Ending on 1-MAY-2024.	01/05
Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting	24/04
Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC	02/04
Corbus Pharmaceuticals Holdings, Inc. Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC	02/04
Corbus Pharmaceuticals Files Mixed Shelf	13/03
Health Care Climbs on Risk Appetite -- Health Care Roundup	12/03
Corbus Pharmaceuticals: Q4 Earnings Snapshot	12/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Corbus Pharmaceuticals Holdings Inc OTC Bulletin Board

Azioni

US21833P1030

Altre lingue

Filtri